Holen Sie sich die Stockscreener-App
2.765
4.61%
0.125
Schlusskurs vom Vortag:
$2.64
Offen:
$2.58
24-Stunden-Volumen:
1.18M
Relative Volume:
1.47
Marktkapitalisierung:
$298.09M
Einnahmen:
$251.42M
Nettoeinkommen (Verlust:
$-202.39M
KGV:
-1.5534
EPS:
-1.78
Netto-Cashflow:
$38.21M
1W Leistung:
-5.75%
1M Leistung:
-14.50%
6M Leistung:
-36.37%
1J Leistung:
-64.18%
1-Tages-Spanne:
$2.54
$2.805
1-Wochen-Bereich:
$2.54
$3.065
52-Wochen-Spanne:
$2.54
$8.33
Definitive Healthcare Corp Stock (DH) Company Profile
Firmenname
Definitive Healthcare Corp
Sektor
Branche
Telefon
508-720-4224
Adresse
492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM
Vergleichen Sie DH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DH
Definitive Healthcare Corp
|
2.77 | 298.09M | 251.42M | -202.39M | 38.21M | -1.78 |
|
VEEV
Veeva Systems Inc
|
227.06 | 37.08B | 2.75B | 714.14M | 1.09B | 4.33 |
|
DOCS
Doximity Inc
|
57.78 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
48.28 | 8.13B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
88.38 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.06 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Definitive Healthcare Corp Stock (DH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-09-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-31 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-17 | Herabstufung | Needham | Buy → Hold |
| 2024-01-05 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-07-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2023-04-19 | Eingeleitet | William Blair | Outperform |
| 2022-12-09 | Eingeleitet | BofA Securities | Neutral |
| 2022-07-06 | Eingeleitet | Needham | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2022-02-24 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-12-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-10-11 | Eingeleitet | Barclays | Equal Weight |
| 2021-10-11 | Eingeleitet | Canaccord Genuity | Hold |
| 2021-10-11 | Eingeleitet | Credit Suisse | Neutral |
| 2021-10-11 | Eingeleitet | Deutsche Bank | Hold |
| 2021-10-11 | Eingeleitet | Goldman | Neutral |
| 2021-10-11 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-11 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-10-11 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-10-11 | Eingeleitet | Stifel | Buy |
Alle ansehen
Definitive Healthcare Corp Aktie (DH) Neueste Nachrichten
Definitive Healthcare stock hits 52-week low at $2.54 - Investing.com India
Definitive Healthcare Corp. (NASDAQ:DH) Shares Purchased by Quantbot Technologies LP - Defense World
DH Stock Price and Chart — NASDAQ:DH - TradingView
Charles Schwab Investment Management Inc. Cuts Stake in Definitive Healthcare Corp. (NASDAQ:DH) - Defense World
Bank of New York Mellon Corp Acquires 60,559 Shares of Definitive Healthcare Corp. (NASDAQ:DH) - Defense World
Spotlight On 3 Penny Stocks With Market Caps Over $60M - Simply Wall St
Connor Clark & Lunn Investment Management Ltd. Boosts Stock Position in Definitive Healthcare Corp. (NASDAQ:DH) - Defense World
Cardinal Health Adds Two Members to Its Board of Directors - HME Business
Definitive Healthcare Corp. (NASDAQ:DH) Given Average Recommendation of “Hold” by Brokerages - Defense World
Definitive Healthcare stock hits 52-week low at $2.57 By Investing.com - Investing.com Australia
Definitive Healthcare stock hits 52-week low at $2.57 - Investing.com India
Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors - BioSpace
Cardinal Health Strengthens Board with Healthcare Analytics, Cybersecurity Experts - StockTitan
Rhumbline Advisers Raises Stock Position in Definitive Healthcare Corp. (NASDAQ:DH) - Defense World
Definitive Healthcare Corp. (NASDAQ:DH) Shares Purchased by Principal Financial Group Inc. - The AM Reporter
Definitive Healthcare at Raymond James Conference: Strategic Focus on Retention - Investing.com
Definitive Healthcare (NASDAQ:DH) Given New $3.00 Price Target at The Goldman Sachs Group - Defense World
Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Definitive Healthcare Attracts Top Talent With Million-Dollar Equity Packages - StockTitan
What 4 Analyst Ratings Have To Say About Definitive Healthcare - Benzinga
Goldman Sachs cuts Definitive Healthcare stock target to $3 - Investing.com
Goldman Sachs cuts Definitive Healthcare stock target to $3 By Investing.com - Investing.com Australia
Definitive Healthcare (NASDAQ:DH) Given New $3.00 Price Target at Barclays - Defense World
Definitive Healthcare’s Earnings Call: Mixed Sentiments Amid Challenges - TipRanks
Definitive Healthcare Corp. (NASDAQ:DH) Q4 2024 Earnings Call Transcript - Insider Monkey
Deutsche Bank Adjusts Definitive Healthcare Price Target to $4 From $5, Maintains Hold Rating - Marketscreener.com
Definitive Healthcare Corp. (NASDAQ:DH) Annual Results: Here's What Analysts Are Forecasting For This Year - Yahoo Canada Finance
Definitive Healthcare stock hits 52-week low at $3.05 By Investing.com - Investing.com Australia
New York State Common Retirement Fund Has $3.17 Million Stake in Definitive Healthcare Corp. (NASDAQ:DH) - Defense World
Definitive Healthcare (NASDAQ:DH) Releases Earnings Results, Misses Estimates By $0.04 EPS - MarketBeat
Definitive Healthcare (NASDAQ:DH) Issues FY 2025 Earnings Guidance - MarketBeat
Definitive Healthcare (NASDAQ:DH) Releases Q1 2025 Earnings Guidance - MarketBeat
Cautious Outlook on Definitive Healthcare Corp Amid Mixed Signals and Challenges - TipRanks
Definitive Healthcare Corp: Hold Rating Amid Retention Challenges and Strategic Opportunities - TipRanks
Definitive Healthcare stock hits 52-week low at $3.05 - Investing.com
Definitive Healthcare Shares Tumble On Weak Q4 Results, 2025 Outlook - Nasdaq
Positive Long-Term Outlook for Definitive Healthcare Corp Despite Current Challenges - TipRanks
Earnings call transcript: Definitive Healthcare Q4 2024 misses EPS, stock drops By Investing.com - Investing.com South Africa
Definitive Healthcare Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Definitive Healthcare stock tumbles on Q4 earnings miss By Investing.com - Investing.com South Africa
Definitive Healthcare Corp. Reports 2024 Financial Results - TipRanks
Definitive Healthcare Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Definitive Healthcare Q4 2024 misses EPS, stock drops - Investing.com India
Definitive Healthcare Corp. (DH) Q4 Earnings and Revenues Surpass Estimates - Nasdaq
Definitive Healthcare earnings missed by $0.58, revenue topped estimates - Investing.com
Definitive Healthcare stock tumbles on Q4 earnings miss - Investing.com
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2024 - The Manila Times
Definitive Healthcare Corp. Reports Q4 and Full Year 2024 Financial Results Amid Goodwill Impairment Charges - Nasdaq
Definitive Healthcare to Present at the Raymond James 2025 Institutional Investors Conference - The Manila Times
Definitive Healthcare Corp expected to post earnings of 7 cents a shareEarnings Preview - TradingView
Healthcare Intelligence Leader DH Executives to Share Strategic Insights at Major Investment Conference - StockTitan
Finanzdaten der Definitive Healthcare Corp-Aktie (DH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
3.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):